Onderzoekers hebben waargenomen dat BPC-157 interageert met het stikstofoxide (NO)-systeem, het dopaminesysteem en de prostaglandineweg, wat wijst op een meervoudig aangrijpend werkingsmechanisme dat verder gaat dan eenvoudige wondafsluiting
Clinical Trial Evidence and Findings in Female Participants Phase 2 trial data (Jastreboff et al., NEJM, 2023) showed dose-dependent weight reduction and metabolic improvements, but sex-disaggregated results were not published, so female-specific efficacy cannot yet be confirmed
For patients with PCOS, this might include Dual Agonist GLP-1 buccal treatment, offered at $199 per month, specifically designed to address challenges like insulin resistance and weight management [5]
You can see it with your own eyes
First line: artificial tears for volume replacement and lubrication Second-line therapies: usually reserved for refractory or severe disease because of their potential adverse effects Stimulation of lacrimal gland function with oral muscarinic agonists, i.e., pilocarpine or cevimeline Topical immunosuppressive agents, e.g., topical cyclosporine, short-term (24 weeks) topical glucocorticoids Serum eye drops Management of systemic disease [5] [9] Management depends on the specific manifestation and should always be guided by a specialist
